1046793-69-4 Usage
Molecular Structure
1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 5-bromo-1-(phenylsulfonyl)is a complex organic compound with a core structure consisting of a fusion of a pyrrole and a pyridine ring. The compound has a carboxamide group attached to the 3-position of the pyridine ring and a 5-bromo-1-(phenylsulfonyl) substituent.
Derivative
This compound is a derivative of pyrrolo[2,3-b]pyridine, which means it is structurally related to the parent compound but has modifications in its chemical structure, such as the presence of the 5-bromo-1-(phenylsulfonyl) group.
Potential Applications
The compound has potential applications in medicinal chemistry, particularly in the development of pharmaceutical drugs. It may exhibit biological activity, making it a candidate for further research and development as a therapeutic agent.
Building Block
1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 5-bromo-1-(phenylsulfonyl)could potentially be used as a building block for synthesizing new molecules with therapeutic properties. This would involve chemical reactions and modifications to create new compounds with desired biological activities.
Chemical Research
Due to its unique structure and potential applications, 1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 5-bromo-1-(phenylsulfonyl)is a promising target for further investigation in chemical research, which could lead to the discovery of new compounds and applications in various fields of science and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1046793-69-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,7,9 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1046793-69:
(9*1)+(8*0)+(7*4)+(6*6)+(5*7)+(4*9)+(3*3)+(2*6)+(1*9)=174
174 % 10 = 4
So 1046793-69-4 is a valid CAS Registry Number.
1046793-69-4Relevant articles and documents
THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE
-
Page/Page column 188, (2008/12/08)
The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and